LivaNova PLC LIVN
LIVN among the 162 companies we cover
Where it stands · the better end on the right. The band holds the middle half; the line is the median.
LIVN and 9 peers, year by year
The 9 Health care companies closest to LIVN in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| LIVN LivaNova PLC | FY2025 | $1.4B | +10.7% | 67.7% | 14.4% | −17.5% | 12.5% | −20.2% | 0.31 |
| ADUS Addus HomeCare Corp | FY2025 | $1.4B | +23.2% | 32.5% | 9.7% | 6.7% | 7.3% | 8.8% | 0.11 |
| INSM INSMED Inc | FY2025 | $606.4M | +66.7% | - | −205.6% | −210.5% | −159.6% | −172.8% | 0.74 |
| PEN Penumbra Inc | FY2025 | $1.4B | +17.5% | 67.1% | 13.5% | 12.7% | 12.5% | 12.4% | - |
| LNTH Lantheus Holdings, Inc. | FY2025 | $1.5B | +0.5% | 61.1% | 20.2% | 15.2% | - | 21.4% | 0.52 |
| MDGL Madrigal Pharmaceuticals, Inc. | FY2025 | $958.4M | +432% | - | −31.3% | −30.1% | −19.8% | −47.8% | 0.56 |
| MMSI Merit Medical Systems Inc | FY2025 | $1.5B | +11.8% | 48.7% | 12.2% | 8.5% | 14.2% | 8.1% | 0.46 |
| HAE Haemonetics Corp | FY2026 | $1.3B | −2.0% | 59.0% | 11.7% | 7.3% | 19.5% | 12.2% | 1.56 |
| PGNY Progyny, Inc. | FY2025 | $1.3B | +10.4% | 23.6% | 6.6% | 4.5% | 14.9% | 11.3% | - |
| GH Guardant Health, Inc. | FY2025 | $982.0M | +32.9% | - | −44.5% | −42.4% | −23.7% | n/m | n/m |
Each company, year by year
Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL
Who rewrote the most
Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before
Revenue, FY2016 to FY2025
Revenue as reported in the 10-K.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| LIVN Dec | $964.9M | $1.0B | $1.1B | $1.1B | $934.2M | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B |
| ADUS Dec | $400.9M | $426.0M | $516.6M | $648.8M | $764.8M | $864.5M | $951.1M | $1.1B | $1.2B | $1.4B |
| INSM Dec | $0 | $0 | $9.8M | $136.5M | $164.4M | $188.5M | $245.4M | $305.2M | $363.7M | $606.4M |
| PEN Dec | $263.3M | $333.8M | $444.9M | $547.4M | $560.4M | $747.6M | $847.1M | $1.1B | $1.2B | $1.4B |
| LNTH Dec | $301.9M | $331.4M | $343.4M | $347.3M | $339.4M | $425.2M | $935.1M | $1.3B | $1.5B | $1.5B |
| MDGL Dec | - | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $180.1M | $958.4M |
| MMSI Dec | $603.8M | $727.9M | $882.8M | $994.9M | $963.9M | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B |
| HAE Mar | - | $886.1M | $903.9M | $967.6M | $988.5M | $870.5M | $993.2M | $1.2B | $1.3B | $1.4B |
| PGNY Dec | - | $48.6M | $105.4M | $229.7M | $344.9M | $500.6M | $786.9M | $1.1B | $1.2B | $1.3B |
| GH Dec | $25.2M | $49.8M | $90.6M | $214.4M | $286.7M | $373.7M | $449.5M | $563.9M | $739.0M | $982.0M |
| Peer median | $282.6M | $331.4M | $343.4M | $347.3M | $344.9M | $500.6M | $847.1M | $1.1B | $1.2B | $1.4B |
Sales growth, FY2016 to FY2025
Revenue against the fiscal year before.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| LIVN Dec | - | +4.9% | +9.4% | −2.1% | −13.8% | +10.8% | −1.3% | +12.9% | +8.7% | +10.7% |
| ADUS Dec | - | +6.3% | +21.3% | +25.6% | +17.9% | +13.0% | +10.0% | +11.3% | +9.1% | +23.2% |
| INSM Dec | - | - | - | n/m | +20.5% | +14.6% | +30.2% | +24.4% | +19.2% | +66.7% |
| PEN Dec | +41.5% | +26.8% | +33.3% | +23.0% | +2.4% | +33.4% | +13.3% | +25.0% | +12.9% | +17.5% |
| LNTH Dec | +2.9% | +9.8% | +3.6% | +1.2% | −2.3% | +25.3% | +120% | +38.6% | +18.3% | +0.5% |
| MDGL Dec | - | - | - | - | - | - | - | - | - | +432% |
| MMSI Dec | - | +20.5% | +21.3% | +12.7% | −3.1% | +11.5% | +7.1% | +9.2% | +7.9% | +11.8% |
| HAE Mar | - | - | +2.0% | +7.0% | +2.2% | −11.9% | +14.1% | +17.7% | +12.0% | +4.0% |
| PGNY Dec | - | - | +117% | +118% | +50.1% | +45.2% | +57.2% | +38.3% | +7.2% | +10.4% |
| GH Dec | - | +97.4% | +81.9% | +137% | +33.8% | +30.3% | +20.3% | +25.5% | +31.0% | +32.9% |
| Peer median | - | +20.5% | +21.3% | +23.0% | +10.1% | +20.0% | +17.2% | +24.7% | +12.4% | +17.5% |
Gross margin, FY2016 to FY2025
Gross profit / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| LIVN Dec | 58.0% | 64.4% | - | 66.8% | 63.7% | 68.2% | 69.2% | 65.5% | 68.1% | 67.7% |
| ADUS Dec | 26.5% | 27.2% | 26.5% | 27.6% | 29.6% | 31.2% | 31.5% | 32.1% | 32.5% | 32.5% |
| INSM Dec | - | - | 75.4% | 82.3% | - | - | - | - | - | - |
| PEN Dec | 64.9% | 65.1% | 65.7% | 68.0% | 60.3% | 63.6% | 63.2% | 64.5% | 63.2% | 67.1% |
| LNTH Dec | 45.6% | 48.9% | 50.9% | 50.3% | 40.9% | 44.1% | 62.2% | 54.7% | 64.4% | 61.1% |
| MDGL Dec | - | - | - | - | - | - | - | - | - | - |
| MMSI Dec | 43.9% | 44.8% | 44.7% | 43.5% | 41.6% | 45.2% | 45.1% | 46.4% | 47.4% | 48.7% |
| HAE Mar | - | 42.7% | 45.6% | 43.2% | 49.0% | 45.7% | 50.9% | 52.6% | 52.8% | 55.0% |
| PGNY Dec | - | 15.2% | 18.4% | 19.8% | 20.3% | 22.4% | 21.3% | 21.9% | 21.7% | 23.6% |
| GH Dec | - | - | - | - | - | - | - | - | - | - |
| Peer median | 44.8% | 43.8% | 45.6% | 43.5% | 41.3% | 44.6% | 48.0% | 49.5% | 50.1% | 51.9% |
Operating margin, FY2016 to FY2025
Operating income / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| LIVN Dec | 3.5% | 9.5% | −22.4% | −15.8% | −29.3% | −0.1% | −7.5% | −5.9% | 10.3% | 14.4% |
| ADUS Dec | 3.9% | 5.9% | 4.4% | 5.4% | 5.8% | 7.6% | 7.2% | 8.6% | 8.9% | 9.7% |
| INSM Dec | - | - | n/m | −172.4% | −161.3% | −199.0% | −186.4% | −232.5% | −241.5% | −205.6% |
| PEN Dec | −0.5% | 0.3% | −0.2% | 8.7% | −6.9% | −1.0% | 0.7% | 6.9% | 0.8% | 13.5% |
| LNTH Dec | 18.7% | 15.6% | 18.8% | 14.9% | −1.2% | −14.3% | 3.9% | 28.1% | 29.8% | 20.2% |
| MDGL Dec | - | - | - | - | - | - | - | - | −276.4% | −31.3% |
| MMSI Dec | 5.8% | 4.5% | 6.6% | 1.6% | −0.2% | 5.7% | 7.6% | 9.9% | 11.5% | 12.2% |
| HAE Mar | - | −2.2% | 6.2% | 8.6% | 10.5% | 10.3% | 8.1% | 13.4% | 12.6% | 16.3% |
| PGNY Dec | - | −22.7% | −3.3% | 4.2% | 2.4% | 6.5% | 3.0% | 5.7% | 5.8% | 6.6% |
| GH Dec | −173.7% | −153.7% | −102.5% | −38.4% | −88.9% | −110.0% | −121.1% | −100.1% | −60.0% | −44.5% |
| Peer median | 3.9% | 0.3% | 4.4% | 4.8% | −0.7% | 2.3% | 3.4% | 7.8% | 5.8% | 9.7% |
Net margin, FY2016 to FY2025
Net income / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| LIVN Dec | −6.5% | −2.5% | −17.1% | −14.5% | −37.3% | −13.1% | −8.4% | 1.5% | 5.0% | −17.5% |
| ADUS Dec | 3.0% | 2.8% | 3.2% | 3.9% | 4.3% | 5.2% | 4.8% | 5.9% | 6.4% | 6.7% |
| INSM Dec | - | - | n/m | −186.4% | −178.9% | −230.6% | −196.3% | −245.6% | −251.2% | −210.5% |
| PEN Dec | 5.6% | 1.4% | 1.5% | 8.9% | −2.8% | 0.7% | −0.2% | 8.6% | 1.2% | 12.7% |
| LNTH Dec | 8.9% | 37.2% | 11.8% | 9.1% | −4.0% | −16.8% | 3.0% | 25.2% | 20.4% | 15.2% |
| MDGL Dec | - | - | - | - | - | - | - | - | −258.6% | −30.1% |
| MMSI Dec | 3.3% | 3.8% | 4.8% | 0.5% | −1.0% | 4.5% | 6.5% | 7.5% | 8.9% | 8.5% |
| HAE Mar | - | −3.0% | 5.0% | 5.7% | 7.7% | 9.1% | 4.4% | 9.9% | 9.0% | 12.3% |
| PGNY Dec | - | −25.6% | 0.6% | −3.7% | 13.5% | 13.1% | 3.9% | 5.7% | 4.7% | 4.5% |
| GH Dec | −182.7% | −167.0% | −93.8% | −35.3% | −88.5% | −103.0% | −145.6% | −85.0% | −59.0% | −42.4% |
| Peer median | 3.3% | 1.4% | 3.2% | 2.2% | −1.9% | 2.6% | 3.4% | 6.7% | 4.7% | 6.7% |
Free cash flow, FY2016 to FY2025
Cash from operations minus capital spending.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| LIVN Dec | $51.8M | $58.4M | $83.3M | −$115.8M | −$114.4M | $77.1M | $43.4M | $39.9M | $135.9M | $173.3M |
| ADUS Dec | −$2.5M | $49.2M | $27.9M | $7.4M | $102.6M | $34.8M | $96.8M | $102.8M | $110.4M | $103.8M |
| INSM Dec | −$150.9M | −$162.6M | −$271.1M | −$292.9M | −$225.6M | −$370.6M | −$410.3M | −$549.5M | −$705.8M | −$967.6M |
| PEN Dec | −$26.4M | $159K | $19.2M | $4.5M | −$58.0M | −$11.7M | −$75.0M | $82.1M | $147.3M | $174.9M |
| LNTH Dec | $42.2M | $37.2M | $41.1M | $58.3M | $16.4M | $53.9M | $21.8M | $259.9M | - | - |
| MDGL Dec | −$17.6M | −$22.4M | −$25.5M | −$41.8M | −$157.9M | −$184.1M | −$225.1M | −$325.7M | −$457.0M | −$190.0M |
| MMSI Dec | $20.8M | $24.1M | $23.2M | −$360K | $119.3M | $119.3M | $69.3M | $110.9M | $185.7M | $215.7M |
| HAE Mar | $19.5M | $83.6M | $145.6M | $40.3M | $109.5M | $71.8M | $75.8M | $81.7M | $143.6M | $142.4M |
| PGNY Dec | - | −$10.1M | $1.7M | −$4.5M | $35.2M | $23.9M | $77.2M | $185.2M | $173.7M | $191.8M |
| GH Dec | −$38.5M | −$78.9M | −$92.4M | −$65.9M | −$140.1M | −$284.1M | −$386.9M | −$345.5M | −$274.9M | −$233.1M |
| Peer median | −$10.0M | $159K | $19.2M | −$360K | $16.4M | $23.9M | $21.8M | $82.1M | $127.0M | $123.1M |
FCF margin, FY2016 to FY2025
Free cash flow / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| LIVN Dec | 5.4% | 5.8% | 7.5% | −10.7% | −12.3% | 7.4% | 4.2% | 3.5% | 10.8% | 12.5% |
| ADUS Dec | −0.6% | 11.5% | 5.4% | 1.1% | 13.4% | 4.0% | 10.2% | 9.7% | 9.6% | 7.3% |
| INSM Dec | - | - | n/m | −214.6% | −137.2% | −196.6% | −167.2% | −180.1% | −194.1% | −159.6% |
| PEN Dec | −10.0% | 0.0% | 4.3% | 0.8% | −10.3% | −1.6% | −8.8% | 7.8% | 12.3% | 12.5% |
| LNTH Dec | 14.0% | 11.2% | 12.0% | 16.8% | 4.8% | 12.7% | 2.3% | 20.0% | - | - |
| MDGL Dec | - | - | - | - | - | - | - | - | −253.7% | −19.8% |
| MMSI Dec | 3.4% | 3.3% | 2.6% | 0.0% | 12.4% | 11.1% | 6.0% | 8.8% | 13.7% | 14.2% |
| HAE Mar | - | 9.4% | 16.1% | 4.2% | 11.1% | 8.2% | 7.6% | 7.0% | 11.0% | 10.5% |
| PGNY Dec | - | −20.8% | 1.6% | −2.0% | 10.2% | 4.8% | 9.8% | 17.0% | 14.9% | 14.9% |
| GH Dec | −152.4% | −158.3% | −101.9% | −30.7% | −48.9% | −76.0% | −86.1% | −61.3% | −37.2% | −23.7% |
| Peer median | −0.6% | 3.3% | 4.3% | 0.4% | 7.5% | 4.4% | 4.2% | 8.3% | 10.3% | 8.9% |
Return on equity, FY2016 to FY2025
Net income / shareholders' equity at the year end.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| LIVN Dec | −3.7% | −1.4% | −12.6% | −11.4% | −31.4% | −10.5% | −7.1% | 1.4% | 4.8% | −20.2% |
| ADUS Dec | 7.9% | 7.0% | 6.1% | 5.3% | 6.4% | 7.9% | 7.3% | 8.8% | 7.6% | 8.8% |
| INSM Dec | −114.1% | −53.4% | −155.7% | −97.2% | −106.6% | −105.9% | n/m | n/m | n/m | −172.8% |
| PEN Dec | 5.6% | 1.2% | 1.6% | 10.0% | −2.4% | 0.6% | −0.2% | 7.7% | 1.2% | 12.4% |
| LNTH Dec | n/m | n/m | 57.1% | 27.6% | −2.6% | −15.3% | 6.3% | 40.0% | 28.7% | 21.4% |
| MDGL Dec | −72.5% | −17.1% | −6.9% | −20.2% | −84.3% | −123.3% | −149.6% | −92.2% | −61.8% | −47.8% |
| MMSI Dec | 4.0% | 4.1% | 4.5% | 0.6% | −1.0% | 4.7% | 6.5% | 7.9% | 8.7% | 8.1% |
| HAE Mar | −7.7% | −3.6% | 6.1% | 8.2% | 13.0% | 10.9% | 5.8% | 14.1% | 12.2% | 20.4% |
| PGNY Dec | - | n/m | n/m | −7.5% | 27.8% | 26.1% | 8.1% | 11.2% | 12.9% | 11.3% |
| GH Dec | −57.9% | −27.0% | −17.6% | −9.5% | −19.5% | −59.7% | n/m | n/m | n/m | n/m |
| Peer median | −7.7% | −3.6% | 3.0% | 0.6% | −2.4% | 0.6% | 6.3% | 8.8% | 8.7% | 10.1% |
Debt / equity, FY2016 to FY2025
Total debt / shareholders' equity at the year end.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| LIVN Dec | 0.09 | 0.08 | 0.11 | 0.25 | 0.59 | 0.19 | 0.45 | 0.46 | 0.48 | 0.31 |
| ADUS Dec | 0.16 | 0.25 | 0.06 | 0.13 | 0.38 | 0.38 | 0.21 | 0.18 | 0.23 | 0.11 |
| INSM Dec | 0.36 | 0.15 | 2.16 | 1.72 | 1.63 | 1.95 | 13.12 | n/m | 3.93 | 0.74 |
| PEN Dec | - | - | - | - | - | - | - | - | - | - |
| LNTH Dec | n/m | 11.51 | 3.75 | 1.69 | 0.42 | 0.38 | 1.25 | 0.69 | 0.52 | 0.52 |
| MDGL Dec | - | - | - | - | - | 0.00 | 0.35 | 0.28 | 0.16 | 0.56 |
| MMSI Dec | 0.65 | 0.42 | 0.43 | 0.46 | 0.37 | 0.23 | 0.17 | 0.68 | 0.53 | 0.46 |
| HAE Mar | 0.57 | 0.43 | 0.34 | 0.52 | 0.65 | 0.97 | 1.03 | 0.94 | 0.84 | 1.49 |
| PGNY Dec | - | - | n/m | - | - | - | - | - | - | - |
| GH Dec | - | - | - | - | - | - | - | - | n/m | n/m |
| Peer median | 0.46 | 0.42 | 0.43 | 0.52 | 0.42 | 0.38 | 0.69 | 0.68 | 0.52 | 0.54 |
EPS (diluted), FY2016 to FY2025
Diluted earnings per share, on today's share count after splits.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| LIVN Dec | −$1.28 | −$0.52 | −$3.91 | −$3.26 | −$7.18 | −$2.68 | −$1.61 | $0.32 | $1.16 | −$4.45 |
| ADUS Dec | $1.07 | $1.03 | $1.33 | $1.77 | $2.08 | $2.81 | $2.84 | $3.83 | $4.23 | $5.22 |
| INSM Dec | −$2.85 | −$2.89 | −$4.22 | −$3.01 | −$3.01 | −$3.88 | −$3.91 | −$5.34 | −$5.57 | −$6.42 |
| PEN Dec | $0.44 | $0.13 | $0.18 | $1.34 | −$0.44 | $0.14 | −$0.05 | $2.32 | $0.36 | $4.52 |
| LNTH Dec | $0.82 | $3.17 | $1.03 | $0.79 | −$0.25 | −$1.06 | $0.40 | $4.65 | $4.36 | $3.41 |
| MDGL Dec | −$5.07 | −$2.54 | −$2.22 | −$5.45 | −$13.09 | −$14.63 | −$17.23 | −$19.99 | −$21.90 | −$12.85 |
| MMSI Dec | $0.45 | $0.55 | $0.78 | $0.10 | −$0.18 | $0.84 | $1.29 | $1.62 | $2.03 | $2.13 |
| HAE Mar | −$1.09 | −$0.51 | $0.85 | $1.04 | $1.48 | $1.55 | $0.84 | $2.24 | $2.29 | $3.31 |
| PGNY Dec | - | −$2.37 | $0.04 | −$0.41 | $0.47 | $0.66 | $0.30 | $0.62 | $0.57 | $0.65 |
| GH Dec | −$3.53 | −$7.07 | −$2.80 | −$0.84 | −$2.60 | −$4.00 | −$6.41 | −$4.28 | −$3.56 | −$3.32 |
| Peer median | −$0.33 | −$0.51 | $0.18 | $0.10 | −$0.25 | $0.14 | $0.30 | $1.62 | $0.57 | $2.13 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out LIVN and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more
Sources
Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.
Also
Financials: LIVN's own statements, year by year. Compare: the whole peer group on one page.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/LIVN/export.csv") into a cell.